Quality use of medicines: Weighing SSRIs and TCAs
Abstract
The review was prompted by a comment on the E-DRUG list after the recent launch of the 13th World Health Organization Model Essential Medicines List. The author, an Oxford academic, noted that amitriptyline remained the only listed antidepressant and expressed the view that 'one of the SSRIs (selective scrotonim reuptake inhibitors) should have been included because of their superiority in terms of side effects, although not in efficacy.
Issue
Section
CPD
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.